Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER)

Clinical trial NCT05684380 · UNKNOWN

Trial details

NCT number: NCT05684380
Sponsor: EMS
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2024-09-01
Primary completion: 2024-11-01
Enrollment: 514

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.